MediPharm Labs Corp (MEDIF)
0.0536
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
MediPharm Labs Debt to Equity Ratio: 0.0397 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.0397 |
December 31, 2023 | 0.0397 |
September 30, 2023 | 0.0446 |
June 30, 2023 | 0.0461 |
March 31, 2023 | 0.0024 |
December 31, 2022 | 0.0093 |
September 30, 2022 | 0.0172 |
June 30, 2022 | 0.0188 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.0192 |
Date | Value |
---|---|
June 30, 2021 | 0.0158 |
March 31, 2021 | 0.0261 |
December 31, 2020 | 0.2285 |
September 30, 2020 | 0.2908 |
June 30, 2020 | 0.131 |
March 31, 2020 | 0.0788 |
December 31, 2019 | 0.0728 |
September 30, 2019 | 0.0465 |
June 30, 2019 | 0.0496 |
March 31, 2019 | 0.1751 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
0.2908
Maximum
Sep 2020
0.0588
Average
0.0397
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Venus Concept Inc | -3.411 |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 0.00 |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 45.33M |
Total Liabilities (Quarterly) | 8.430M |
Shareholders Equity (Quarterly) | 36.90M |
Current Ratio | 3.069 |
Net Debt Paydown Yield | -0.84% |